Broadcast Retirement Network's Jeffrey Snyder discusses the state of investment in the life sciences with scientist and biotech expert, Andrew R. Snyder, PhD. Jeffrey Snyder, Broadcast Retirement ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

The life sciences industry is experiencing transformative shifts driven by technological innovation and urgent global health needs. AAA Biotech, a leading provider of premium research reagents, is ...

The expanded team brings decades of experience spanning biotechnology, AI, and commercialization–advancing Salt AI’s mission to help translational scientists and drug developers accelerate discovery ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. PALO ALTO, Calif. — At an annual meeting usually focused on the industry’s future, ...

Doug’s goal is to help entrepreneurial scientists create successful startups. To this end, Doug and his colleagues have systematically lowered the barriers between great ideas and successful companies ...

Emerging from a grassroots LinkedIn group effort and with co-founder Rob Perez leaning in to grow the initiative, 2026 is shaping up to be the year of BLOC—Biopharma Leaders of Color. “The thing that ...

Two lab-ready buildings at 8025 and 8045 Lamon Avenue inside the Illinois Science + Technology Park in Skokie are up for ...

Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

The Joseph Henry Press, an imprint of the National Academy Press, was created with the goal of making books on science, technology, and health more widely available to profes- sionals and the public.

The layoffs come as the company finishes its acquisition of Arcellx.